Role of inflammation and oxidative stress in atrial fibrillation.

[1]  D. R. Wagoner.  Oxidative Stress and Inflammation in Atrial Fibrillation: Role in Pathogenesis and Potential as a Therapeutic Target , 2008 .

[2]  E. Varol,et al.  N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. , 2008, European heart journal.

[3]  D. Rader,et al.  The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans. , 2008, Journal of the American College of Cardiology.

[4]  N. Lakkis,et al.  Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. , 2007, Journal of the American College of Cardiology.

[5]  H. Otu,et al.  Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study. , 2007, The Annals of thoracic surgery.

[6]  Dean P. Jones,et al.  Oxidative stress markers are associated with persistent atrial fibrillation. , 2007, Clinical chemistry.

[7]  D. Roden,et al.  Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation. , 2007, Heart rhythm.

[8]  J. Morrow,et al.  Quantification of F2-isoprostanes as a biomarker of oxidative stress , 2007, Nature Protocols.

[9]  P. Ellinor,et al.  C-Reactive protein in lone atrial fibrillation. , 2006, The American journal of cardiology.

[10]  S. Gupte,et al.  Novel roles for nox oxidases in cardiac arrhythmia and oxidized glutathione export in endothelial function. , 2005, Circulation research.

[11]  J. Ruskin,et al.  Clinical Subtypes of Lone Atrial Fibrillation , 2005, Pacing and clinical electrophysiology : PACE.

[12]  D. H. Thiel,et al.  Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? , 2005, Free radical biology & medicine.

[13]  G. Lip,et al.  Atrial fibrillation, the prothrombotic state, inflammation, and gender. , 2005, The American journal of cardiology.

[14]  D. Kremastinos,et al.  Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. , 2005, The American journal of cardiology.

[15]  J. Morrow.  Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[16]  P. Montuschi,et al.  Isoprostanes: markers and mediators of oxidative stress , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Ben He,et al.  Differential expression of cytokines in the rat heart in response to sustained volume overload , 2004, European journal of heart failure.

[18]  G. Lip,et al.  Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. , 2004, Journal of the American College of Cardiology.

[19]  T. Horinouchi,et al.  C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation? , 2004, Japanese heart journal.

[20]  Bruce M Psaty,et al.  Inflammation as a Risk Factor for Atrial Fibrillation , 2003, Circulation.

[21]  J. Goudevenos,et al.  Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. , 2003, Medical science monitor : international medical journal of experimental and clinical research.

[22]  R. Yee,et al.  Lessons from the implantable atrial defibrillator. , 2003, American heart journal.

[23]  S. Basu,et al.  Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans. , 2003, Free radical biology & medicine.

[24]  Cynthia A. Carnes,et al.  C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation , 2001, Circulation.

[25]  M. Chung,et al.  Ascorbate Attenuates Atrial Pacing-Induced Peroxynitrite Formation and Electrical Remodeling and Decreases the Incidence of Postoperative Atrial Fibrillation , 2001, Circulation research.

[26]  D. V. Van Wagoner,et al.  Impaired Myofibrillar Energetics and Oxidative Injury During Human Atrial Fibrillation , 2001, Circulation.

[27]  A. Nozari,et al.  Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest , 2000, FEBS letters.

[28]  李永军,et al.  Atrial Fibrillation , 1999 .

[29]  D. Wagner,et al.  Differential regulation of cardiac expression of IL-6 and TNF-α by A2- and A3-adenosine receptors. , 1999, American journal of physiology. Heart and circulatory physiology.

[30]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[31]  M. Russo,et al.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.

[32]  S. Ommen,et al.  Atrial arrhythmias after cardiothoracic surgery. , 1997, The New England journal of medicine.

[33]  K. Channon,et al.  Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. , 2008, Journal of the American College of Cardiology.

[34]  M. Pan,et al.  Inflammation: a possible pathogenic link to atrial fibrillation. , 2006, Medical hypotheses.

[35]  J. Morrow,et al.  Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. , 1994, Methods in enzymology.